SHSE:605199 (China)
Â
Class A
Â¥
5.9
-0.13 (-2.16%)
Sep 3
Business Description
Hainan Huluwa Pharmaceutical Group Co Ltd
ISIN : CNE100004223
Share Class Description:
SHSE:605199: Class ATotal Employee Number:
1,451Compare
Compare
Traded in other countries / regions
605199.China Index Membership
SSE Composite Index IPO Date
2020-07-10Description
Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in the Research, development, production and sales of traditional Chinese medicine and chemical drugs.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.12 | |||||
Debt-to-Equity | 3.51 | |||||
Debt-to-EBITDA | -2.98 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.15 | |||||
Beneish M-Score | -2.41 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.3 | |||||
3-Year Book Growth Rate | -25.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.07 | |||||
9-Day RSI | 55.31 | |||||
14-Day RSI | 54.15 | |||||
3-1 Month Momentum % | -14.46 | |||||
6-1 Month Momentum % | -16.45 | |||||
12-1 Month Momentum % | -38.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.51 | |||||
Quick Ratio | 0.37 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 189.58 | |||||
Days Sales Outstanding | 245.37 | |||||
Days Payable | 327.81 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.29 | |||||
Operating Margin % | -42.46 | |||||
Net Margin % | -63.59 | |||||
EBITDA Margin % | -55.55 | |||||
FCF Margin % | 21.99 | |||||
OCF Margin % | 26.37 | |||||
ROE % | -81.03 | |||||
ROA % | -15.17 | |||||
ROIC % | -11.2 | |||||
3-Year ROIIC % | -46.93 | |||||
ROC (Joel Greenblatt) % | -23.15 | |||||
ROCE % | -27.51 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 73.44 | |||||
PS Ratio | 3.88 | |||||
PB Ratio | 7.89 | |||||
Price-to-Tangible-Book | 84.29 | |||||
Price-to-Free-Cash-Flow | 18.27 | |||||
Price-to-Operating-Cash-Flow | 15.13 | |||||
EV-to-EBIT | -9.85 | |||||
EV-to-EBITDA | -9.85 | |||||
EV-to-Revenue | 5.47 | |||||
EV-to-FCF | 24.88 | |||||
Price-to-GF-Value | 1.32 | |||||
Earnings Yield (Greenblatt) % | -10.15 | |||||
FCF Yield % | 5.91 | |||||
Forward Rate of Return (Yacktman) % | -35.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hainan Huluwa Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 634.036 | ||
| EPS (TTM) (Â¥) | -1.004 | ||
| Beta | 1.0751 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.79 | ||
| Volatility % | 35.14 | ||
| 14-Day RSI | 54.15 | ||
| 14-Day ATR (Â¥) | 0.171754 | ||
| 20-Day SMA (Â¥) | 5.994 | ||
| 12-1 Month Momentum % | -38.35 | ||
| 52-Week Range (Â¥) | 5.15 - 10.37 | ||
| Shares Outstanding (Mil) | 400.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hainan Huluwa Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hainan Huluwa Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hainan Huluwa Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Hainan Huluwa Pharmaceutical Group Co Ltd(SHSE:605199)'s stock price today?
The current price of SHSE:605199 is ¥5.90. The 52 week high of SHSE:605199 is ¥10.37 and 52 week low is ¥5.15.
When is next earnings date of Hainan Huluwa Pharmaceutical Group Co Ltd(SHSE:605199)?
The next earnings date of Hainan Huluwa Pharmaceutical Group Co Ltd(SHSE:605199) is .
Does Hainan Huluwa Pharmaceutical Group Co Ltd(SHSE:605199) pay dividends? If so, how much?
Hainan Huluwa Pharmaceutical Group Co Ltd(SHSE:605199) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hainan Huluwa Pharmaceutical Group Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers